Class II

Drug Recall: Fasenra (benralizumab) Injection, 30 mg/mL, one single-dose pre-filled syringe, Rx only, Manufactured by: AstraZeneca AB, Sweden, Distributed by: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850.

ASTRAZENECA PHARMACEUTICALS · October 8, 2025

Reason for Recall

Lack of Assurance of Sterility:

Product Description

Fasenra (benralizumab) Injection, 30 mg/mL, one single-dose pre-filled syringe, Rx only, Manufactured by: AstraZeneca AB, Sweden, Distributed by: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850. NDC 0310-1730-30

Distribution

Nationwide in the U.S

States Affected

NATIONWIDE

Quantity Affected

916 pre-filled syringes

Source: FDA (openFDA Drug Enforcement)

Recall number: D-0028-2026

Status: ongoing

SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.